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Abstract: Fumonisins are mycotoxins produced by Fusarium verticillioides and  
F. proliferatum, fungi that are ubiquitous in corn (maize). Insect damage and some other 
environmental conditions result in the accumulation of fumonisins in corn-based products 
worldwide. Current methods of fumonisin detection rely on the use of immunoaffinity 
columns and high-performance liquid chromatography (HPLC). The use of aptamers offers 
a good alternative to the use of antibodies in fumonisin cleanup and detection due to lower 
costs and improved stability. Aptamers are single-stranded oligonucleotides that are 
selected using Systematic Evolution of Ligands by EXponential enrichment (SELEX) for 
their ability to bind to targets with high affinity and specificity. Sequences obtained after 
18 rounds of SELEX were screened for their ability to bind to fumonisin B1. Six unique 
sequences were obtained, each showing improved binding to fumonisin B1 compared to 
controls. Sequence FB1 39 binds to fumonisin with a dissociation constant of 100 ± 30 nM 
and shows potential for use in fumonisin biosensors and solid phase extraction columns.  
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1. Introduction  
Molecular recognition plays an essential role in various biological and biomedical applications, 
particularly in biosensor development. In its simplest form, a biosensor consists of a specific molecular 
recognition probe targeting an analyte of interest and a means of converting that recognition event into 
a measurable signal. While antibodies have been the gold standard for molecular recognition elements 
for several decades, the relatively new technology of aptamers is emerging as a valuable molecular 
recognition tool. Aptamers are single stranded oligonucleotides that fold into distinct nanoscale shapes 
capable of binding to a target molecule. Aptamer-target recognition occurs through a combination of 
hydrogen bonding, electrostatic interactions, van der Waals forces and stacking interactions. As 
molecular recognition probes, aptamers have binding affinities and specificities that are comparable to, 
and in some cases even surpass those of monoclonal antibodies. The ability of aptamers to fold into 
distinct 3-D conformations allows high affinity binding and selectivity for their target. For example, 
dissociation constants in the nanomolar or picomolar range have been achieved with aptamers. 
Furthermore, aptamers can discriminate targets on the basis of subtle structural differences such as 
chirality [1] or the presence or absence of a single methyl group [2]. Targets for which aptamers have 
been developed range from small molecules, such as nucleotides [3], to complex macromolecules, 
such as proteins [4] and even whole cells [5]. In certain applications, aptamer technology offers several 
advantages over antibodies. First, high-purity aptamers can be chemically synthesized at a low cost 
and can be easily modified with dyes and labels without affecting their affinities. Second, aptamers are 
more chemically stable under most environmental conditions, have a longer shelf life, and can be 
reversibly denatured without loss of specificity. These properties make aptamers attractive in the 
development of low-cost, robust diagnostics and biosensors [6].  
There is a growing need for rapid, inexpensive methods for the detection of contaminations in food 
and feed, both in the field and post-harvest. As molecular recognition is the cornerstone of sensing, 
there has been increased focus on the development of new molecular recognition probes for  
food-safety related targets. Toxic fungal metabolites, known as mycotoxins, can contaminate a wide 
range of agricultural commodities, and are high priority targets for the development of new molecular 
recognition probes and biosensors. It is estimated that at least 25% of the grain produced worldwide is 
contaminated with mycotoxins [7]. However, even small concentrations of mycotoxins can induce 
significant health problems including vomiting, kidney disease, liver disease, cancer and death. Thus, 
aptamers displaying high affinity and selectivity for such toxins would be useful in the development of 
sensitive biosensing systems enabling simple and rapid detection. The development of aptamers for 
mycotoxins is of particular interest as the antibodies used for mycotoxin detection are susceptible to 
denaturation in the presence of solvents commonly used in their extraction [8]. An aptamer for the 
mycotoxin ochratoxin A (OTA) has already been developed and integrated into several detection 
systems [9,10]. For example, the OTA aptamer has been used in the preparation of solid phase 
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extraction columns for OTA clean-up from naturally contaminated wheat samples prior to liquid 
chromatographic (HPLC) analysis. Comparative analysis using traditional immunoaffinity clean-up 
procedures showed a good correlation between the two methods [11]. Additionally, the OTA aptamer 
has been incorporated into a colorimetric detection system utilizing gold nanoparticles, where accurate 
measurements can be done in less than 5 minutes [12]. Aptamer-based electrochemical and 
electrochemiluminescent sensors have also been developed using the OTA aptamer. These systems are 
sensitive, displaying detection limits of 30 pg/mL and 7 pg/mL, respectively [13,14]. Other mycotoxin 
aptamers are also in development worldwide [15,16]. 
The mycotoxin Fumonisin B1 (FB1) is a nephrotoxin in all species tested, a carcinogen in rodents 
and a reproductive toxicant in rodents and likely in humans [17]. The Joint Expert Committee on Food 
Additives and Contaminants of the WHO established a Provisional Maximum Daily Intake which is 
being applied in different areas as a function of corn-based food consumption and exposures [18]. 
Unlike food-contaminating bacteria, FB1 is not inactivated by cooking temperatures, therefore careful 
monitoring of cereals is essential prior to distribution for consumption [19]. Given its toxicity and 
prevalence, several analytical methods have been reported for the detection of FB1. These include 
enzyme-linked immunosorbent assay, capillary zone electrophoresis and high performance liquid 
chromatography technologies [20]. While these methods are effective, the need for highly trained 
personnel and expensive equipment make them inaccessible in all but the most well-equipped 
laboratories as well as impractical for rapid testing at country elevators, for example. Thus, a  
tight-binding aptamer for FB1 could be an important tool for the development of new fumonisin  
clean-up and detection systems. 
Aptamers are discovered using an in vitro process called Systematic Evolution of Ligands by 
EXponential enrichment (SELEX), a procedure where target-binding oligonucleotides are selected 
from a random pool of sequences through iterative cycles of affinity separation and amplification  
(see Figure 1) [21,22]. The SELEX process begins with a large random oligonucleotide library (pool), 
whose complexity and diversity is dependent on the number of its random nucleotide positions [23].  
Figure 1. Schematic overview of the Systematic Evolution of Ligands by EXponential 
enrichment (SELEX) procedure. 
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During the SELEX procedure, separation of the binding DNA from the sequences lacking affinity is 
required. Typically, this is achieved by immobilizing the target of interest to a column matrix, usually 
agarose or sepharose, allowing easy partitioning of unwanted sequences through multiple washes. 
However, a more recent SELEX method termed FluMag SELEX makes use of magnetic beads as the 
solid matrix [24]. These beads can be surface-functionalized with almost any chemical group to allow 
for easy covalent attachment of a target. Additionally, only a relatively small amount of target is 
required for efficient conjugation to the beads compared to conventional column materials.  
The next steps in SELEX include the elution of the binding sequences from the target and the 
polymerase chain reaction (PCR) amplification of those binders to yield an enriched pool for 
subsequent, more stringent, selection rounds. As the interactions that lead to molecular recognition 
between the binding sequences and the target are non-covalent in nature, relatively mild conditions can 
be used to separate the two species. Elution is typically performed using high concentrations of the 
target molecule, high temperatures or hydrogen-bond-disrupting compounds such as urea. Once 
separated from the target, the few binding DNA sequences are amplified by PCR to yield a practical 
amount of sample to continue the process  
The enriched pool generated from this first round of selection is then subjected to further selection 
rounds that serve to increase the pool’s affinity for the target molecule (positive selections) or 
eliminate members of the pool that have affinity for undesirable compounds (negative selections). 
After several rounds, the enriched pool is cloned, sequenced, and characterized to find aptamers with 
the desired properties. Once these sequences are elucidated, solid-phase chemical synthesis is used to 
reproducibly synthesize aptamers in large quantities. During aptamer synthesis, a multitude of 
chemical modifications are possible, such as end-labeling for covalent attachment or backbone 
modification for increased stability, optimizing the aptamer’s properties for certain applications [25]. 
In this way, aptamers are ideal for many molecular recognition applications such as diagnostics and 
therapeutics. For example, aptamer-based biosensors have been developed for use in a variety of fields 
from medicine, to environmental monitoring and food safety [26,27].  
The production of an aptamer for FB1 is the first step in the realization of inexpensive, robust and 
innovative detection technology that could offer a solution to the limitations of the existing detection 
techniques. In turn, this testing process may be simple enough to be performed by crop handlers and 
agricultural inspectors in the field, ultimately reducing the exposure of the mycotoxin to animals and 
humans around the globe. This paper discusses the selection of FB1-binding aptamer sequences and an 
initial assessment of their binding affinity. 
2. Results and Discussion 
2.1. Fumonisin B1 Immobilization 
In order to easily separate binding DNA from non-binding DNA, immobilization of the target to a 
solid matrix is necessary. As magnetic separation technology is fast, simple and effective, the use of 
surface modified magnetic beads is a superior alternative to conventional immobilization on sepharose 
or agarose. In particular, substantially less target is required for efficient immobilization compared to 
the amounts required for column immobilization [28]. This is particularly important in the case of 
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expensive or rare targets such as FB1. Carboxylic acid modified beads were chosen due to the simple 
coupling chemistry possible with the sole primary amine of FB1. Fumonisin B2, B3 and B4 all have this 
amine, which could allow for a similar aptamer selection protocol for these other members of the 
fumonisin family in the future. In addition, some evidence has shown that the primary amine is a 
critical part of the anti-FB1 antibody binding epitope. Conjugation via the amine would likely force our 
aptamer to exclude the amine in its binding epitope, which could allow for the development of 
antibody/aptamer sandwich assays [19].  
Successful conjugation of the target FB1, was confirmed using HPLC. O-phthaldialdehyde (OPA) 
derivatized FB1 was fluorescently detected at a retention time of approximately six minutes. 
Quantification of unbound FB1 using a standard curve, measured as the total peak area, showed  
1–5 nmol of target successfully conjugated to aliquots of 5 × 108 beads. Comparison of the 
immobilized FB1 in the presence and absence of the required coupling agent,  
1-ethyl-3-(3-dimethylaminopropyl) carbodiimide hydrochloride (EDC), showed that a small amount of 
FB1 (approximately 0.1 nmol) can non-specifically interact with the carboxylic acid surface  
activated beads.  
2.2. Selection of Aptamers 
Careful consideration was made when choosing the selection buffer for this experiment. Since the 
DNA backbone is polyanionic, the negative–negative charge repulsion may inhibit formation of 
complex structures in the absence of counterions such as Na
+
. This may ultimately impede binding 
with the target. Divalent cations in particular, such as Mg
2+
, block the negative charge repulsion and 
allow the backbone to form tighter folding. Interestingly, aptamers with higher affinity show less 
magnesium dependence than weaker binding aptamers [29]. Therefore, performing SELEX under low 
magnesium concentrations, such as physiological conditions (1–2.5 mM Mg2+), may increase the 
stringency of selection conditions, leading to the production of high-affinity binding aptamers. While 
the only other mycotoxin aptamer, the OTA aptamer, was selected under buffer conditions lacking 
calcium, an increase in binding affinity was observed upon the addition of calcium ions [9]. It is 
suggested that the OTA forms a coordination complex with divalent ions such as calcium with the aid 
of the carboxyl and hydroxyl groups. Calcium was included in the buffer for this experiment to allow 
for a similar coordination complex that may form between neighboring carboxyl groups in fumonisin. 
Many published aptamers fold into g-quadruplex structures such as the thrombin-binding aptamer [4], 
the DNA aptamer for hematoporphyrin [30] and the HIV-1 integrase aptamer [31]. Potassium was 
included in the selection buffer since monovalent cations, especially K
+
, are required to help stabilize 
g-rich sequences into these guanosine tetrads.  
While aptamers have been selected using a variety of random region lengths within the initial 
library, a 60 nucleotide length was chosen for these experiments. A minimum of 25 nucleotides should 
be employed to achieve a diversity of 10
15
 different sequences. Generally, as the length of the random 
region increases, the structural complexity of the library increases. This increase in complexity allows 
for the presence of complex structures such as 4 and 5-way junctions, which are often high-affinity 
binders [32]. For this reason, lengths over 200 nucleotides have been used. However, practical 
limitations reduce the number of initial sequences that can actually be used for the first selection round 
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to 10 nmol or less. Therefore, as the length of the random region increases, sequence space becomes 
substantially under-sampled. An initial library with 60 random nucleotides was chosen to strike a 
balance between these two competing factors. 
When performing SELEX on a solid matrix for target immobilization, it is extremely important to 
ensure that any sequences displaying binding properties towards the matrix and/or the linker arm are 
eliminated. Once aptamers are generated, they are typically used to measure free target in solution, 
therefore any aptamer affinity derived from any partial binding to the matrix will reduce the 
functionality of the aptamer for sensing applications. For example, the published rhodamine aptamer 
displays a weaker binding to the target rhodamine when in solution compared to when it is 
immobilized on the matrix used in the selection [33]. To mitigate this, it is necessary to remove all 
sequences that display even weak binding or partial recognition to the matrix. Typical SELEX 
experiments do this by performing a pre-selection step prior to the first selection round to remove any 
initial sequences displaying this unwanted binding [34]. However, as mutation and evolution of the 
pool occurs with each selection and amplification step, we performed this negative selection prior to 
each round to ensure as much as possible that our pool was only binding to the target. To further 
enhance the selectivity of our aptamers, we performed our negative selection using various targets 
beginning at round 4. These negative selection steps, often called counter selections, remove any 
sequences from the pool that bind to structurally similar molecules, or molecules that may be found in 
a sample containing our target of interest. Jenison et al. found that using this counter selection 
technique generated an aptamer for theophylline that displayed a 10,000-fold weaker binding to 
caffeine, two molecules which differ only by a single methyl group [2]. Counter selections using  
L-homocysteine (rounds 5–10), L-cysteine and L-methionine (rounds 11–15) immobilized to the 
magnetic beads were used, since these amino acids could be easily coupled to the beads via the amino 
group. Pool sequences that only bind to any exposed carboxylic acid functional group would be 
removed by these negative selections. Similarly, in the last three rounds, L-glutamic acid (round  
16–18) was then used as a counter selection to eliminate sequences with affinity for other similar 
carboxylic acid containing molecules. A negative selection using FB2 was not employed in our 
selections for several reasons. The difference between these two structures is very subtle: FB2 lacks the 
11-hydroxy group. While aptamers have been selected that can recognize as small a difference as this, 
the counter selection against FB2 would likely severely reduce the DNA pool and eliminate many high 
affinity binders. The loss of high affinity binders in order to gain selectivity may not be worthwhile in 
this case as FB2 is often found in samples containing FB1. The European Commission maximum 
tolerable intakes include the total of FB1 and FB2 intake; therefore, total fumonisin is often  
detected [35]. Note that the absence of counter selections against FB2 does not guarantee that the 
selected aptamers will be able to bind both targets. 
To assess the enrichment of the library for target binding, as well as to determine when increased 
stringency could be applied to the selection, the percent binding of the DNA pool was monitored after 
each round using fluorescence and absorbance measurements (see Figure 2). Typical selection matrices 
include µmol amounts of target [36]. However, due to the cost and availability of the target FB1, as 
well as the possibility of using minute concentrations of target with the magnetic beads, our selection 
matrix contained a maximum of 5 nmol of target. In the later rounds, the amount of target available for 
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binding could be as low as 20 pmol (1:5 ratio of FB1:DNA). This accounts for the seemingly low 
percent recovery of binding sequences with each round.  
Figure 2. Percent recovery of binding ssDNA to the FB1 immobilized magnetic beads after 
each selection round. With any observable significant increase or plateau in percent 
recovery, increasingly stringent selection conditions were implemented the following 
round (see Section 3 and Table 1). 
 
 
In the initial few rounds, the maximum amount of target immobilized beads (5 × 10
8
 beads) was 
used for selections. This was to ensure complete capture of binding sequences. However, every  
4–5 rounds, the number of magnetic beads used for positive selection, and therefore the amount of 
target available for binding, was reduced 2- to 5-fold (see Table 1). This decrease in the concentration 
of the target increased the stringency of the selection round, allowing for competition between 
sequences within the selection. Competition for the fewer binding sites should ultimately yield  
tighter-binding aptamers. Tok et al. described a novel method to generate DNA aptamers by using a 
single target-immobilized microbead. They found that the weak binding aptamers were displaced by 
the higher affinity aptamers. After only two selection cycles, aptamers displaying dissociation 
constants in the low nanomolar range were obtained [37].  
Two other conditions were manipulated to increase the stringency of selections. First, non-binding 
aptamers were washed away with column buffer (prior to elution) only three times in the initial rounds. 
As the number of rounds increased, this was increased to eight washing steps to wash away not only 
the non-binding sequences but also any weaker-binding sequences. Second, the binding incubation 
time was slowly decreased as the selections progressed (see Table 1). In the initial rounds, a one hour 
period was used to allow for slow folding or refolding in the presence of the target. However, in the 
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last rounds, 20 minute incubations were used since higher affinity binding species can be readily 
selected within a short equilibration time [34]. 
Table 1. Summary of selection round conditions. 
Selection 
Round 
Negative Selection Used Number of FB1 
derivatized beads 
used 
Incubation time with 
FB1 derivatized beads 
(min) 
1 Unmodified 5 × 10
8 
60 
2 Unmodified 5 × 10
8
 60 
3 Unmodified 5 × 10
8
 60 
4 Unmodified 5 × 10
8
 60 
5 L-homocysteine 1 × 10
8
 60 
6 L-homocysteine 1 × 10
8
 60 
7 L-homocysteine 1 × 10
8
 45 
8 L-homocysteine 1 × 10
8
 45 
9 L-homocysteine 1 × 10
8
 45 
10 L-homocysteine 5 × 10
7
 45 
11 L-cysteine and L-methionine 5 × 10
7
 45 
12 L-cysteine and L-methionine 5 × 10
7
 30 
13 L-cysteine and L-methionine 5 × 10
7
 30 
14 L-cysteine and L-methionine 5 × 10
7
 30 
15 L-cysteine and L-methionine 1 × 10
7
 30 
16 L-glutamic acid 1 × 10
7
 30 
17 L-glutamic acid 1 × 10
7
 30 
18 L-glutamic acid 1 × 10
7
 20 
Several methods are possible for the elution of target-binding sequences. Direct cleavage of the 
target-bound aptamer from the bead was not possible in this case. While elution by affinity with free 
ligand is typically the method of choice [34], the amount required for successful elution for each round 
(often up to 50 mM) of 98% purity would cost over $5,000. Typically, the target used for elution 
should be as pure as possible: this would cost closer to $12,000 if obtained through a standard 
chemical supply house. For this reason, the elution methods available included changing the ionic 
strength or use of denaturants. We found that simply changing the ionic strength by the addition of 
metal chelators, such as (Ethylenedinitrilo)tetraacetic acid disodium salt (EDTA), or using deionized 
water, only allowed removal of weak binders. This is not surprising as some aptamers have been 
shown to maintain their binding in the absence of Na
+
 and K
+
 cations [9]. To fully remove the high 
affinity binders, several long elutions with 7 M urea at 90 °C were required. However, to ensure our 
final aptamers would bind to FB1 free in solution, elution with pure FB1 was performed in the last two 
selection rounds. As high affinity binders in these late rounds of SELEX should have very long 
residence times, a few long elution times were performed to completely remove all bound species. 
Following elution in these last two rounds, extensive clean-up to remove the FB1 from the binding 
sequences was required as the FB1 inhibited PCR and quenched fluorescence measurements.  
Six unique sequences were obtained after cloning from round 18 (see Table 2). Surprisingly, 
sequences having the highest incidence (FB1 31 and FB1 39) have the lowest G content. Typically, 
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aptamers are G rich, for example, the DNA aptamer for OTA (47% G) [9], the DNA aptamer for  
ATP (45%) [3], the DNA cocaine aptamer (32%) [38] and the DNA aptamer for  
fibronectin (33%) [39].  
Table 2. Full length sequences obtained after selection round 18. 
Sequence 
5'-ATACCAGCTTATTCAATT-N
60
-
AGATAGTAAGTGCAATCT-3'  
G Content 
(%) 
Sequence Incidence  
(% of Total) 
FB
1 
14 CTATACGGAGTGGATATCGATCTGTAACGT
GAGTGAGATAATGTGATGCATAGTCGTGG  32  12.5  
FB
1 
16 CATCCAGTAACAAACACATAAGTAACGGC
GATATGTCAAAGCGGTATCGGCTACAGATG  22  12.5  
FB
1 
23  GCGGATGCGTAAATGACGATAAACATAGAT
GGGGTATATCGCGATGCGACAGGGTGT  35  12.5  
FB
1 
31  CGGGGACGTGTATACCAGCTTATTCAATTC
ACAGTTATGTCCTATACCAGCTTATTCAATT  17 25  
FB
1 
32  AATGTACGATGTGTGGGCAACATGAGTATG
TCGTGTGATATCTAGATGAGGTAGCGGTGG  37  12.5  
FB
1 
39  AATCGCATTACCTTATACCAGCTTATTCAAT
TACGTCTGCACATACCAGCTTATTCAATT  8  25  
The selected sequences were folded using Mfold [40] (see Figure 3). The resulting predicted 
secondary structures are all of very low complexity; all sequences are 1-way junction structures. While 
this is typical of several aptamers (almost a quarter of all aptamers are 1-way junctions [32]), some 
evidence has shown that higher complexity can lead to higher affinity [41]. For this reason, attempts 
have been made to increase the structural complexity of the initial libraries used in SELEX, which 
would result in more complex aptamers [32]. At this early stage, however, it is unclear if the large, 
initially unstructured regions of these sequences are involved in target binding, nor is it known whether 
these stretches fold in the presence of the target molecule as a result of new molecular interactions. 
These questions will be addressed in our future work. 
2.3. Binding Assays 
Each aptamer clone was tested for its ability to bind to FB1 derivatized beads using a fluorescence 
binding assay. This allowed for comparative determination of the relative binding ability of each 
aptamer generated in the selection experiment. The selection conditions used in the SELEX 
experiment were used for these binding assays, using aliquots of FB1 derivatized beads as the target. 
To remove any non-binding or weakly-bound DNA, many washes were performed. Bound DNA was 
eluted first with column buffer at 90 °C. Elution using high temperatures is sufficient to denature most 
target-DNA interactions; however, the addition of the denaturant urea, in our experience, is able to 
displace even the strongest, non-covalent, interaction. The comparison of binding DNA eluted only 
with 90 °C buffer compared to 90 °C urea can be found in Figure 4. The specific binding of the 
aptamers to the target was compared to binding of the unenriched initial library (Control Pool). 
Binding assays were also performed on unmodified (control) magnetic beads. This was done to ensure 
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that the individual clones were binding specifically to FB1 and not simply non-specifically interacting 
with the surface of the magnetic beads. 
Figure 3. Secondary structure prediction for the full length clones. Image generated by Mfold. 
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Figure 4. Binding assays of the individual aptamer sequences against FB1 beads compared 
to the unmodified beads (labeled as control beads). The percent of DNA eluted with buffer 
at 90 °C is in blue, the DNA eluted using 7 M urea at 90 °C is in grey. The unenriched 
(Control Pool) was tested on the FB1 modified beads as a comparison. 
 
Control pool, before any enrichment, has a small degree of non-specific affinity for the beads, as 
evidenced by the low percentage of DNA bound. This amount is comparable to the non-specific 
binding seen between each of the sequences and the unmodified beads (Control Beads). For most 
sequences, 50% or more of the DNA non-specifically bound to the unmodified beads can be removed 
using the 90 °C buffer, indicative that these interactions are relatively weak. The opposite is true in the 
case of the aptamer sequences and their affinity for FB1 beads. Across all sequences, a 2- to 5-times 
increase in affinity is seen in the presence of the target, and all required high concentrations of 90 °C 
urea in order to remove the majority of the bound sequences. The observed percent binding of the 
aptamer sequences is sizeable for this type of assay. A similar binding assay performed using 
streptavidin conjugated magnetic beads by Stoltenburg et al. showed a maximum percent binding of 
21% for their aptamer clones. Despite their lower binding percents observed, their aptamers were 
found to bind to the target with dissociation constants in the low nanomolar range [24]. 
Interestingly, FB1 39, which yielded the highest binding to the target, contains the lowest guanosine 
content (only 8%). As mentioned earlier, this is atypical of most aptamers. This sequence is slightly T 
enriched (35%) compared to C (27%) or A (30%). While less common, there is some precedent for  
T-rich aptamer sequences. For example, the DNA aptamer for tubulin is a T-rich aptamer displaying 
binding in the micromolar range. The random library used in their selection was also able to generate 
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G-rich aptamers for other targets such as chitin, indicating that the T-rich aptamer property is specific 
for the target type and not simply a chance event due to the nature of the original pool [42]. 
The binding affinity of sequence FB1 39 was investigated in more detail and was found to interact 
with immobilized FB1 with a dissociation constant, KD, of 100 ± 30 nM (see Figure 5). Therefore, this 
full length aptamer clone displays a high affinity for this relatively small molecular target. Comparable 
binding of the aptamer to the target when in solution is expected and will be determined in our future 
work. Further analysis will also attempt to identify the minimal target-binding sequence to shorten the 
aptamer and improve binding while lowering the aptamer’s production cost. 
Figure 5. Binding curves for the aptamer sequence FB1 39. Three trials were performed to 
obtain saturation curves used to determine the dissociation constant (KD). Bound 
fluorescein-labeled aptamer was measured by fluorescence (excitation at 490 nm, emission 
at 518 nm).  
 
As with the OTA aptamer, the effect of binding in an increased concentration of calcium will also 
be studied. The initial full length aptamer for OTA displayed a KD of 360 nM. After identifying the 
minimal binding sequence and adding calcium to the binding buffer, the OTA aptamer displayed a KD 
as low as 54 nM. A similar situation may be expected with our FB1 39 sequence. Therefore, 
dissociation constants for the final minimal aptamer will be determined and cross-reactivity tests will 
be run against other mycotoxins such as fumonisin B2. Stability of the aptamer under typical fumonisin 
extraction conditions and the feasibility of incorporating the aptamer into solid phase extraction 
columns and biosensor systems will be examined.  
3. Experimental Section 
3.1. Reagents 
DNA synthesis reagents were purchased from Glen Research (Sterling, VA, U.S.). Magnetic beads 
were purchased from Bangs Laboratories Inc. (Fishers, IL, U.S.). Fumonisin B1 was produced and 
purified in our laboratory according to Miller et al. [43]. All PCR and electrophoresis components 
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were purchased from BioShop Canada Inc. (Burlington, ON, Canada). Chemicals for buffer solutions 
and all other purposes were purchased from Sigma-Aldrich (Oakville, ON, Canada). 
3.2. Derivatization of Magnetic Beads 
ProMag 3 Series Carboxylic acid Surfactant Free Bangs magnetic beads were covalently modified 
with fumonisin B1 through its primary amine according to the instructions from the beads 
manufacturer. Aliquots of 500 µL (approximately 5 × 10
8 
beads) were washed several times with 
Coupling Buffer (0.1 M K2HPO4, 0.15 M NaCl (pH 5.5)) and the beads were magnetically separated 
from the supernatant using a Dynal MPC-S, 6 × 1.5mL tube magnet. 500 µL of a 0.05 mM FB1 
solution was reacted with the beads both in the presence and absence of excess  
1-ethyl-3-(3-dimethylaminopropyl)carbodiimide (EDC) hydrochloride (~5 mM) for 60 minutes. To 
determine successful immobilization, unbound FB1 remaining in the supernatant was measured using 
HPLC with fluorescence detection after derivatization with OPA reagent as described by  
Visconti et al. [44]. Separation was achieved with a C18 reverse phase HPLC column (5 µm, 250 × 4.6 mm) 
using a methanol: 0.1 M NaH2PO4 (77:23 v/v, pH 3.35) solvent system. Bound FB1 was calculated as 
the difference between the initial and unbound concentrations in the supernatants. Separate aliquots of 
beads were derivatized with one of L-homocysteine, L-cysteine, L-methionine or L-glutamic acid for 
counter selection steps. 
3.3. DNA Library and Primer Synthesis 
The starting DNA library was synthesized on a 1 µmol scale on a MerMade 6 Oligonucleotide 
synthesizer (BioAutomation Corporation, USA) using standard phosphoramidite chemistry. The 
sequence is 96 nucleotides in length, containing a central region of 60 random nucleotides flanked by 
two primer binding sites necessary for PCR and cloning: 5'-ATACCAGCTTATTCAATT-N60-
AGATAGTAAGTGCAATCT-3'. The following primers used for amplification and cloning of the 
selected oligonucleotides were synthesized: Primer1: 5'- ATACCAGCTTATTCAATT-3' and Primer2: 
5'-AGATTGCACTTACTATCT-3'. Modified primers were also synthesized to allow for fluorescent 
labeling of the binding DNA and separation of strands on a denaturing polyacrylamide gel: ModPrimer 
1: 5'-fluorescein-ATACCAGCTTATTCAATT-3' and ModPrimer 2 5'-poly-dA20-HEG-
AGATTGCACTTACTATCT-3'. All synthesized DNA was purified through denaturing 
polyacrylamide gel electrophoresis (12%) followed by clean-up with Amicon YM-3 Centrifugal  
Filter Devices. 
3.4. SELEX Experiments  
Fresh aliquots of FB1 derivatized beads and unmodified beads or beads modified with a counter 
selection target were washed 5-times with 0.5 mL of Column Buffer (100 mM NaCl, 20 mM Tris,  
2 mM MgCl2, 5 mM KCl, 1 mM CaCl2, pH 7.6) before each SELEX round. Prior to the first selection, 
the pool (2 nmol) was suspended in 0.5 mL of column buffer and heated for 10 minutes at 90 °C then 
cooled at 4 °C for 15 minutes, followed by incubation at room temperature for at least 7 minutes. In 
subsequent rounds, 100 pmol of pool was used. The pool was first incubated with either unmodified 
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beads or beads derivatized with counter selection target molecules with mild shaking for 60 minutes. 
Only DNA lacking affinity for the unmodified beads or counter selection targets was collected by 
removal of the bead supernatant. This pool, devoid of sequences displaying non-specific affinity, was 
subjected to the same heating and cooling process described above, followed by incubation with a 
varying amount of FB1 derivatized beads and for a specific amount of time, depending on the 
stringency of binding selection desired (see Table 1). Following incubation, sequences with little to no 
affinity for FB1 were removed by washing 3–8 times with 0.1 mL of Column Buffer. DNA bound to 
the FB1 was then removed with 7 M urea at 90 °C. Five elution fractions of 0.1 mL each, were 
collected, purified using Amicon Ultra 3 KDa 0.5 mL centrifugal filters and quantified using  
UV-visible spectroscopy and/or fluorescence. In the final two selection rounds, binding DNA was 
removed with five 30 minute elutions using 0.2 mM FB1.  
The entire selected oligonucleotide pool was amplified in 15–30 parallel PCR reactions for the first 
round, in subsequent rounds only 90% of the selected pool was amplified with the remaining 10% set 
aside for analysis and in case of PCR failure. Each reaction consisted of 0.1 M Tris HCl pH 9, 50 mM 
KCl, 1% Triton X-100, 2.0 mM MgCl2, 0.2 mM dNTP mix, 1 μM each modified primer and 5 units of 
Taq DNA polymerase. The DNA was initially melted for 10 minutes at 94 °C, followed by 25 cycles 
of 94 °C (1 min), 47 °C (1 min) and 72 °C (1 min). Final extension occurred at 72 °C for  
10 minutes after the last cycle. In rounds 10–18, asymmetric PCR (1:50 ratio of primers, 35 cycles) 
was performed to facilitate the isolation of the aptamer strand from the complement. PCR products 
were dried down, heated at 55 °C for 5 minutes in the presence of formamide and run through a 12% 
denaturing PAGE to separate the double stranded product. The fluorescein labeled DNA strand (the 
selected sequences) could be identified using an Alpha Imager UV-illuminator. The corresponding 
DNA bands were cut from the gel and extracted using the freeze/rapid thaw method described by Chen 
and Ruffner [45] in 10 mM Tris HCl buffer, pH 7.4. The DNA was then purified using the Amicon 
centrifugal filters, quantified and re-suspended in column buffer and could be used in the next 
selection round. 
Enrichment of the DNA pool was assessed throughout the rounds of selection by monitoring the 
percent of DNA pool binding to the FB1 derivatized beads using UV-vis and fluorescence 
measurements. After round 16, no additional enrichment was observed; therefore a total of 18 selection 
rounds were performed. 
3.5. Cloning and Sequencing 
The enriched DNA pool obtained from SELEX round 18 was PCR amplified using the unmodified 
primers (Primer 1 and 2) and cloned using the StrataClone PCR Cloning Kit (Agilent Technologies, 
Mississauga, ON, Canada). Positive colonies (white) were picked and a small portion of the plaque 
was removed carefully and transferred to the Templiphi sample buffer. DNA was prepared for 
sequencing by rolling-circle amplification using the TempliPhi Amplification kit (GE Healthcare, 
Canada). These samples were sent for full service sequencing at the University of Calgary University 
Core DNA Services (AB, Canada). The 6 unique sequences were tested for binding to FB1.  
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3.6. Binding Assays 
The fluorescein-labeled (6-FAM) sequences to be tested (6 unique sequences obtained from the 
cloning experiment and some unenriched pool prior to SELEX) were synthesized on a 1 µmol scale 
using standard phosphoramidite chemistry. Sequence synthesis was verified through molecular weight 
verification using electrospray ionization (ESI) mass spectrometry (Novatia LLC, Monmouth Junction, 
NJ, USA). Each sequence was heated to 90 °C for 10 minutes, cooled to 4 °C and incubated at room 
temperature for 7 minutes. Aliquots of 2 × 10
8
 FB1 derivatized beads were washed with column buffer 
and incubated for 30 minutes at room temperature with 9 to 15 pmol of each DNA sequence 
separately. Non-binding DNA was removed with several washing steps using column buffer. Bound 
DNA was eluted first with two 0.1 mL fractions of column buffer at 90 °C for 10 minutes each. To 
ensure complete removal of bound DNA, elution using two fractions of 0.1 mL 7 M urea at 90 °C for  
10 minutes was also performed. The percent of DNA eluted with column buffer and urea were 
determined using fluorescence (excitation at 490 nm, emission at 518 nm) and calculation using 
calibration curves. The same experiment was performed on unmodified beads to ensure the observed 
binding of sequences was specific to the target. 
3.7. Determination of the Dissociation Constant 
The dissociation constant was obtained for aptamer sequence FB1 39. Binding assays were 
performed as above, by exposing varying concentrations of aptamer (1 nM to 1 µM) to 2 × 10
8
 FB1 
derivatized beads in column buffer. Non-binding DNA was removed by washing five times. Bound 
DNA was eluted with two 0.1 mL fractions of column buffer at 90 °C for 10 minutes each. The 
fluorescence of the eluted aptamer was recorded and the dissociation constants were evaluated by 
minimizing the residual values between calculated and observed experimental ∆fluorescence data 
using the solver feature of Microsoft Excel [46]. This experiment was performed three times to obtain 
the reported dissociation constant. 
4. Conclusions 
Eighteen rounds of increasingly stringent selection conditions were performed in order to obtain 
DNA sequences displaying high binding affinity to fumonisin B1. Of the six individual sequences 
obtained from the SELEX experiment, several candidates displayed superior binding to the target 
compared to controls. Aptamer sequence FB1 39, displaying low complexity and an unexpectedly low 
percent of G, displayed the highest percent binding to the target. This sequence, displaying a 
dissociation constant in the nanomolar range, will be further processed to optimize the length and 
binding affinity to fumonisin. This aptamer is a promising tool for use in fumonisin clean-up and 
detection systems to efficiently detect low levels of fumonisin in food commodities. This aptamer may 
allow the development of a testing process simple enough to be performed by maize handlers and 
agricultural inspectors in the field and greatly reduce the exposure of animals and humans to FB1.  
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